Results from the VOYAGER PAD Trial reported
A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The ...
Oct 19, 2020
0
1